Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp. Share · CA00258G1037 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Abattis Bioceuticals Corp.
No Price
Closing Price OTC 30.04.2026: 0,00003 USD
30.04.2026 20:00
Current Prices from Abattis Bioceuticals Corp.
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
ATTBF
USD
30.04.2026 20:00
0,00003 USD
-
Company Profile for Abattis Bioceuticals Corp. Share
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

Company Data

Name Abattis Bioceuticals Corp.
Company Abattis Bioceuticals Corp.
Website https://www.abattis.com
Primary Exchange OTC UTC
ISIN CA00258G1037
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Francesco Paolini
Country Canada
Currency USD
Employees -
Address 625 Howe Street, V6C 2M6 Vancouver
IPO Date 2014-05-29

Stock Splits

Date Split
11.09.2012 1:5

Ticker Symbols

Name Symbol
Over The Counter ATTBF
More Shares
Investors who hold Abattis Bioceuticals Corp. also have the following shares in their portfolio:
Cosel Co., Ltd.
Cosel Co., Ltd. Share
Zur Shamir Holdings Ltd
Zur Shamir Holdings Ltd Share